feature photo

Research Areas

HIV Prevention

The IMPAACT HIV Prevention Scientific Committee aims to develop and test biomedical/behavioral interventions to prevent HIV maternal acquisition and mother-to-child transmission (MTCT) and to prevent secondary transmission from perinatally HIV-infected adolescents to sexual partners. Evaluating interventions that prevent MTCT and allow HIV-infected women to safely breastfeed while optimizing their own and their child’s health is a major priority in the developing world. Likewise, secondary transmission from perinatally infected adolescents to sexual partners is a growing area of concern. Priorities include evaluation of:

  • Interventions to prevent mother-to-child HIV transmission in the perinatal period and during breastfeeding while optimizing infant and maternal health outcomes, including HIV vaccines.
  • Safe, effective, and feasible interventions to reduce incident HIV infection in pregnant and breastfeeding women and their partners.
  • Biomedical and behavioral interventions to reduce transmission of HIV from perinatally HIV-infected adolescents to sexual partners.

Committee Contacts

Chair: Lynda Stranix-Chibanda
Vice-Chair: Sybil Hosek
Operations Center: Kate Lypen and Kathy George

Presentations

2016 IMPAACT Annual Meeting Prevention Scientific Committee presentations

2015 IMPAACT Annual Meeting Prevention Scientific Committee presentation

Studies Within This Research Area

IMPAACT 2009
IMPAACT P1112
IMPAACT 1077BF
IMPAACT 1077FF
IMPAACT 1077HS

 

 

 

 

 

 

 

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.